Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes

NCT05815342 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT05815342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05815342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes
Lead sponsor
Insulet Corporation
Phase
Not applicable
Overall status
Completed
Start date
April 11, 2023
Completion date
March 1, 2024
Enrollment
343 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes